A detailed history of Nuveen Asset Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 3,957,054 shares of DHR stock, worth $913 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
3,957,054
Previous 3,871,069 2.22%
Holding current value
$913 Million
Previous $967 Million 13.73%
% of portfolio
0.32%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $20.6 Million - $24.1 Million
85,985 Added 2.22%
3,957,054 $1.1 Billion
Q2 2024

Aug 09, 2024

SELL
$235.51 - $267.98 $17.8 Million - $20.2 Million
-75,424 Reduced 1.91%
3,871,069 $967 Million
Q1 2024

May 13, 2024

BUY
$224.58 - $256.19 $72.5 Million - $82.7 Million
322,686 Added 8.9%
3,946,493 $986 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $7.73 Million - $9.73 Million
-41,743 Reduced 1.14%
3,623,807 $838 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $102 Million - $117 Million
439,669 Added 13.63%
3,665,550 $909 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $16.2 Million - $18.4 Million
-72,019 Reduced 2.18%
3,225,881 $774 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $10.3 Million - $11.9 Million
42,947 Added 1.32%
3,297,900 $831 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $221 Million - $259 Million
-916,100 Reduced 21.96%
3,254,953 $864 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $81.1 Million - $495 Million
328,151 Added 8.54%
4,171,053 $1.08 Billion
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $27 Million - $34.2 Million
-114,032 Reduced 2.88%
3,842,902 $974 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $102 Million - $125 Million
396,489 Added 11.14%
3,956,934 $1.14 Billion
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $55 Million - $61.9 Million
-188,236 Reduced 5.02%
3,560,445 $1.17 Billion
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $41.7 Million - $51 Million
-153,348 Reduced 3.93%
3,748,681 $1.14 Billion
Q2 2021

Aug 16, 2021

BUY
$225.08 - $271.69 $143 Million - $173 Million
635,957 Added 19.47%
3,902,029 $1.05 Billion
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $3.67 Million - $4.25 Million
-17,272 Reduced 0.53%
3,266,072 $735 Million
Q4 2020

May 17, 2021

SELL
$212.5 - $245.46 $1.27 Million - $1.47 Million
-5,974 Reduced 0.18%
3,283,344 $729 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $28.2 Million - $32.6 Million
-132,704 Reduced 3.88%
3,289,318 $731 Million
Q3 2020

Nov 16, 2020

SELL
$177.16 - $215.33 $29.7 Million - $36.1 Million
-167,706 Reduced 4.67%
3,422,022 $737 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $39.4 Million - $54.1 Million
-305,755 Reduced 7.85%
3,589,728 $635 Million
Q1 2020

May 14, 2020

BUY
$121.39 - $169.05 $33.3 Million - $46.4 Million
274,252 Added 7.57%
3,895,483 $539 Million
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $10.6 Million - $12.2 Million
-79,620 Reduced 2.15%
3,621,231 $556 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $4.86 Million - $5.26 Million
35,927 Added 0.98%
3,700,851 $535 Million
Q2 2019

Aug 15, 2019

BUY
$124.88 - $143.73 $453 Million - $522 Million
3,631,465 Added 10853.48%
3,664,924 $524 Million
Q1 2019

May 14, 2019

BUY
$97.62 - $132.29 $33,483 - $45,375
343 Added 1.04%
33,459 $4.42 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $109,931 - $126,956
1,159 Added 3.63%
33,116 $3.42 Million
Q3 2018

Nov 13, 2018

BUY
$98.13 - $108.9 $179,087 - $198,742
1,825 Added 6.06%
31,957 $3.47 Million
Q1 2018

May 14, 2018

SELL
$92.16 - $103.8 $1,566 - $1,764
-17 Reduced 0.06%
30,132 $2.95 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $255,438 - $283,481
2,996 Added 11.03%
30,149 $0
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $2.15 Million - $2.4 Million
27,153
27,153 $2.33 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.